Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WU, J.
Right arrow Articles by WATSON, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WU, J.
Right arrow Articles by WATSON, J. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Protein Science, Vol 7, Issue 4 1017-1028, Copyright © 1998 by Cold Spring Harbor Laboratory Press

ARTICLE

Trapping of intermediates during the refolding of recombinant human epidermal growth factor (hEGF) by cyanylation, and subsequent structural elucidation by mass spectrometry

J. WU, Y. YANG and J. T. WATSON
Present address: 9NM, AP20, Diagnostic Division, Abbott Laboratories, Abbott Park, Illinois 60064.

Human epidermal growth factor (hEGF) contains 53 amino acids and three disulfide bonds. The unfolded, reduced hEGF is allowed to refold under mildly alkaline conditions. The folding is quenched at different time points by adjusting the pH to 3.0 with an acetic acid solution of 1-cyano-4-dimethylamino-pyridinium (CDAP) which traps folding intermediates via cyanylation of free sulfhydryl groups. The mixture of cyanylated intermediates is separated by reversed-phase HPLC; the fractions collected are identified by mass spectrometry. The disulfide structures of the intermediates are then determined by specific chemical cleavage and mass-mapping by MALDI-MS, a novel approach developed in our laboratory. The procedure of quenching and trapping of disulfide intermediates in acidic solution minimizes sulfhydryl-disulfide exchange, and therefore provides a good measure of folding kinetics and preservation of intermediate species. Our cyanylation methodology for disulfide mapping is simpler, faster, and more sensitive than the more conventional approach. Among 18 folding intermediates isolated and identified at different time points, disulfide structures of seven well-populated intermediates, including two non-native isomers with scrambled disulfide structures, one 2-disulfide intermediate, and four 1-disulfide intermediates, have been characterized; most of them possess non-native disulfide structures.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. L. Arolas, S. Bronsoms, J. Lorenzo, F. X. Aviles, J.-Y. Chang, and S. Ventura
Role of Kinetic Intermediates in the Folding of Leech Carboxypeptidase Inhibitor
J. Biol. Chem., September 3, 2004; 279(36): 37261 - 37270.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
U. Goransson and D. J. Craik
Disulfide Mapping of the Cyclotide Kalata B1: CHEMICAL PROOF OF THE CYCLIC CYSTINE KNOT MOTIF
J. Biol. Chem., November 28, 2003; 278(48): 48188 - 48196.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
X.-Y. Jia, Z.-Y. Guo, Y. Wang, Y. Xu, S.-S. Duan, and Y.-M. Feng
Peptide models of four possible insulin folding intermediates with two disulfides
Protein Sci., November 1, 2003; 12(11): 2412 - 2419.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z.-S. Qiao, C.-Y. Min, Q.-X. Hua, M. A. Weiss, and Y.-M. Feng
In Vitro Refolding of Human Proinsulin. KINETIC INTERMEDIATES, PUTATIVE DISULFIDE-FORMING PATHWAY, FOLDING INITIATION SITE, AND POTENTIAL ROLE OF C-PEPTIDE IN FOLDING PROCESS
J. Biol. Chem., May 9, 2003; 278(20): 17800 - 17809.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
H. Yan, Z.-Y. Guo, X.-W. Gong, D. Xi, and Y.-M. Feng
A peptide model of insulin folding intermediate with one disulfide
Protein Sci., April 1, 2003; 12(4): 768 - 775.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-Y. Chang
The Folding Pathway of alpha -Lactalbumin Elucidated by the Technique of Disulfide Scrambling. ISOLATION OF ON-PATHWAY AND OFF-PATHWAY INTERMEDIATES
J. Biol. Chem., January 4, 2002; 277(1): 120 - 126.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
J.-Y. Chang, L. Li, and A. Bulychev
The Underlying Mechanism for the Diversity of Disulfide Folding Pathways
J. Biol. Chem., March 17, 2000; 275(12): 8287 - 8289.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Yang, J. Wu, and J. T. Watson
Probing the Folding Pathways of Long R3 Insulin-like Growth Factor-I (LR3IGF-I) and IGF-I via Capture and Identification of Disulfide Intermediates by Cyanylation Methodology and Mass Spectrometry
J. Biol. Chem., December 31, 1999; 274(53): 37598 - 37604.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-Y. Chang, L. Li, and P.-H. Lai
A Major Kinetic Trap for the Oxidative Folding of Human Epidermal Growth Factor
J. Biol. Chem., February 9, 2001; 276(7): 4845 - 4852.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by The Protein Society.